Guide: Questions to ask your human biological specimen provider
Posted: 2 July 2019 | BioIVT | No comments yet
The foundations for protecting human research subjects come from the ethical principles surrounding the Belmont report : Respect for persons, beneficence, and justice.
The use of human biospecimens in research supports these principles with legal and ethical regulations – the most important of which is permission.(1) As either a researcher or purchaser of Human Biological Specimens (HBS) for research, you need to ensure that your HBS provider operates within the limits of the regulatory oversite that is required for HBS procurement as well as in line with the best practices that have been developed over years by groups specializing in optimizing HBS procurement. Below are key questions that should be asked of every HBS provider.
Related content from this organisation
- How to block trogocytosis and improve CAR T-cell therapy
- A “hot” issue: TGF -β and checkpoint inhibitor resistance
- Product hub: CD34+ haematopoietic stem cells: One cell type, multiple viable sources
- Whitepaper: Disease state primary cells bring verification and validation studies closer to real-world results
- Whitepaper: Isolation of tumour infiltrating lymphocytes from dissociated tumour cells
Related topics
Clinical Trials, Research & Development
Related organisations
BioIVT
